Iaso Therapeutics, Inc. is a biopharmaceutical and biotechnology company headquartered in East Lansing, Michigan, dedicated to redefining infectious disease prevention and drug research.
Subscribe to see Iaso Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Iaso Therapeutics, Inc. is a company headquartered in United States. Its most recent funding round raised $570,000 in January 2026. Xcout tracks 6 named people at Iaso Therapeutics, Inc., including Robert Forgey (President and CEO).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $570,000 | — | |
| SEC Form D filing | $437,850 | — | |
| Series C1 | $1.3M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Iaso Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
IASO BioMed, Inc., also known as IASO Bio, is a biotherapeutics and biotechnology company headquartered in Nanjing, China.
Iaso Ventures is a venture capital firm that invests in early-stage healthcare and life sciences startups. The company focuses on data-driven enabling technologies and platforms aimed at advancing next-generation therapeutics to cure diseases and improve patient outcomes.
Io Therapeutics, Inc. is a privately held biopharmaceutical company based in Houston, Texas, dedicated to discovering and developing therapeutic compounds.
NanoBio Corp. is a biopharmaceutical company based in Ann Arbor, Michigan, focused on developing dermatological products and anti-infective treatments.
Island Pharmaceuticals Ltd is an Australian antiviral drug development company based in Melbourne, Australia, focused on addressing infectious diseases.
Aridis Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing novel, differentiated therapies for infectious diseases, with its headquarters located in Los Gatos, California.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.